BPI Boston 2026 (BioProcess International Conference & Exhibition) is one of the most influential international conferences and exhibitions for global bioprocessing and biopharmaceutical manufacturing. The event brings together biopharmaceutical enterprises, CDMOs, research institutions, equipment suppliers and technology service providers worldwide to discuss cutting‑edge technologies, process innovations and industrial development trends spanning R&D through commercial‑scale manufacturing.

Visit VDO Biotech at Booth #1425

VDO Biotech will participate in BPI Boston 2026. At this exhibition, We look forward to engaging with biopharmaceutical companies, CDMOs and industry experts across the globe to foster partnerships and business connections.

Advanced Separation and Purification Solutions for Bioprocessing

At BPI Boston 2026, VDO Biotech will showcase a comprehensive portfolio of chromatography resins designed to support diverse purification challenges across biologics development and manufacturing.

From antibody purification and recombinant protein purification to biosimilar production, vaccine purification, and cell & gene therapy applications, our solutions combine proven purification technologies with advanced resin innovation. Our Chromatography Resins include Ion Exchange Resins, Affinity Resins, Multimodal Resins, and Size Exclusion Resins.

VDX Chromatography Resins -Engineered for Next-Level Purification Performance

VDX Chromatography Resins will be a key highlight at the exhibition. Engineered with optimized ligand design and advanced matrix structures, VDX resins are developed to overcome the limitations of conventional chromatography media, delivering enhanced purification performance, improved process efficiency, and reliable scalability.

✔ High purification efficiency

✔ Improved product recovery

✔ Enhanced scalability and process consistency

From laboratory development to commercial manufacturing, VDX Chromatography Resins help bioprocess teams achieve more efficient, robust, and controllable purification workflows.

l  Ion Exchange Resins: VDX HQ / HS / XQ / XS

l  Affinity Resins: VDX NTA Ni ultra, VDX VH3

l  Multimodal Resins: VDX MMA ultra, VDX Core A

Featured Scientific Presentation: Improving Antibody Purification Efficiency with VDX MMA ultra

During BPI Boston 2026, VDO Biotech’s Chief Scientist, Dr. Liao Jiali, will deliver a technical presentation. He will introduce VDX MMA ultra, an advanced mixed-mode chromatography resin featuring a novel ligand design with optimized ligand conformation and orientation.

About VDO Biotech

Founded in 2014, VDO Biotech is an innovator in bioprocessing, molecular diagnostics, and life science research. With over 18,000 m² of R&D and manufacturing facilities and a team where 30% of employees are dedicated to R&D, VDO Biotech combines scientific expertise with advanced manufacturing capabilities to develop reliable technologies that accelerate discovery, advance diagnostics, and improve human health.

Supported by a global partner network across 50+ countries, VDO Biotech provides high-performance products and technical expertise to researchers, biotechnology companies, and pharmaceutical manufacturers worldwide.

Meet VDO Biotech at BPI Boston 2026

Meet our team and explore how VDO Biotech’s purification technologies can support your next-generation biologics development programs. We warmly invite you to visit us at Booth #1425. To schedule an onsite meeting with our experts, please contact us: 

📩 Email: vdo@vdobiotech.com